Search

everythinglearnresearchcommunity

for

Search:↓

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

CCCA can affect both genders and all ages, and it has a genetic component.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Intralesional cidofovir may be a viable alternative treatment for SCC.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

CCCA mainly affects Black women and is linked to high-tension hairstyles, heating tools, chemical relaxants, and genetics.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

There is no standard treatment for CCCA, and practices vary widely.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.